Non-invasive urine tests for monitoring bladder cancer
Evaluation of Pre-Analytical Factors of Urine Samples for Urine Cancer Cell Cultures (UCCC) --A Non-Invasive Biomarker – in Monitoring Response and Recurrence of Bladder Cancer
This study is testing a new, easier way to check for bladder cancer using urine samples, which could help find out if the cancer comes back and how well treatments are working, making it more comfortable for patients than older methods.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project ID | NIH-10922790 on NIH RePORTER |
What this research studies
This research focuses on developing a new method to monitor bladder cancer using urine samples. By utilizing a technique called conditional reprogramming, researchers aim to create cancer cell cultures from urine, which can help detect cancer recurrence and predict responses to treatments. This approach is designed to be less invasive and more comfortable for patients compared to traditional methods like cystoscopy. The goal is to improve patient outcomes and reduce healthcare costs associated with bladder cancer monitoring.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with bladder cancer who are undergoing treatment or monitoring for recurrence.
Not a fit: Patients with other types of cancer or those who are not currently diagnosed with bladder cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a more accessible and cost-effective way for patients to monitor bladder cancer recurrence.
How similar studies have performed: Previous research has shown promise in using non-invasive biomarkers for cancer detection, suggesting that this approach could be effective.
Where this research is happening
Columbus, UNITED STATES
- Ohio State University — Columbus, United States (Active)
Researchers
- Principal investigator: Liu, Xuefeng — Ohio State University
- Study coordinator: Liu, Xuefeng
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.